Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Cardiac failure congestive? 990 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 990 reports of Cardiac failure congestive have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.2% of all adverse event reports for ADALIMUMAB.

990
Reports of Cardiac failure congestive with ADALIMUMAB
0.2%
of all ADALIMUMAB reports
144
Deaths
636
Hospitalizations

How Dangerous Is Cardiac failure congestive From ADALIMUMAB?

Of the 990 reports, 144 (14.5%) resulted in death, 636 (64.2%) required hospitalization, and 30 (3.0%) were considered life-threatening.

Is Cardiac failure congestive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 990 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Cardiac failure congestive?

ROSIGLITAZONE (15,085) METFORMIN\ROSIGLITAZONE (1,408) LENALIDOMIDE (1,373) AMBRISENTAN (1,359) SACUBITRIL\VALSARTAN (1,355) APIXABAN (1,144) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,129) AVANDIA (1,102) MACITENTAN (979) TREPROSTINIL (955)

Which ADALIMUMAB Alternatives Have Lower Cardiac failure congestive Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Cardiac failure congestive Reports All Drugs Causing Cardiac failure congestive ADALIMUMAB Demographics